Avid Bioservices Inc (NASDAQ: CDMO) kicked off on Tuesday, up 4.21% from the previous trading day, before settling in for the closing price of $6.41. Over the past 52 weeks, CDMO has traded in a range of $4.07-$19.97.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 24.30% over the past five years. While this was happening, its average annual earnings per share was recorded -2666.67%. With a float of $62.54 million, this company’s outstanding shares have now reached $62.69 million.
Let’s look at the performance matrix of the company that is accounted for 365 employees.
Avid Bioservices Inc (CDMO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Avid Bioservices Inc is 1.11%, while institutional ownership is 91.00%. The most recent insider transaction that took place on Jan 12 ’24, was worth 1,855. In this transaction Chief Commercial Officer of this company sold 274 shares at a rate of $6.77, taking the stock ownership to the 19,829 shares. Before that another transaction happened on Jan 10 ’24, when Company’s Chief Financial Officer sold 2,408 for $6.17, making the entire transaction worth $14,857. This insider now owns 79,305 shares in total.
Avid Bioservices Inc (CDMO) Latest Financial update
In the latest quarterly report, which was put into the public domain on 10/31/2023, the organization reported 0.01 earnings per share (EPS), higher than consensus estimate (set at -0.03) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2666.67% per share during the next fiscal year.
Avid Bioservices Inc (NASDAQ: CDMO) Trading Performance Indicators
Take a look at Avid Bioservices Inc’s (CDMO) current performance indicators. Last quarter, stock had a quick ratio of 0.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Avid Bioservices Inc (CDMO)
Avid Bioservices Inc (NASDAQ: CDMO) saw its 5-day average volume 0.77 million, a negative change from its year-to-date volume of 1.26 million. As of the previous 9 days, the stock’s Stochastic %D was 19.36%. Additionally, its Average True Range was 0.47.
During the past 100 days, Avid Bioservices Inc’s (CDMO) raw stochastic average was set at 54.83%, which indicates a significant increase from 37.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.50% in the past 14 days, which was lower than the 100.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.03, while its 200-day Moving Average is $8.21. Nevertheless, the first resistance level for the watch stands at $6.86 in the near term. At $7.03, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.30. If the price goes on to break the first support level at $6.41, it is likely to go to the next support level at $6.14. The third support level lies at $5.97 if the price breaches the second support level.
Avid Bioservices Inc (NASDAQ: CDMO) Key Stats
The company with the Market Capitalisation of 422.44 million has total of 63,239K Shares Outstanding. Its annual sales at the moment are 149,270 K in contrast with the sum of 560 K annual income. Company’s last quarter sales were recorded 25,400 K and last quarter income was -9,510 K.
